HAVN Life Sciences Inc.
HAVLF · OTC
4/30/2022 | 4/30/2021 | 4/30/2020 | |
|---|---|---|---|
| Assets | – | – | – |
| Cash & Equivalents | $1,056 | $9,402 | $1,617 |
| Short-Term Investments | $0 | $0 | $0 |
| Receivables | $151 | $210 | $0 |
| Inventory | $1,149 | $359 | -$251 |
| Other Curr. Assets | $389 | $639 | $576 |
| Total Curr. Assets | $2,745 | $10,610 | $1,943 |
| Property Plant & Equip (Net) | $356 | $681 | $0 |
| Goodwill | $0 | $0 | $0 |
| Intangibles | $934 | $2,931 | $0 |
| Long-Term Investments | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 |
| Other NC Assets | $24 | $18 | $0 |
| Total NC Assets | $1,314 | $3,630 | $0 |
| Other Assets | $0 | $0 | $0 |
| Total Assets | $4,059 | $14,240 | $1,943 |
| Liabilities | – | – | – |
| Payables | $321 | $535 | $41 |
| Short-Term Debt | $79 | $131 | $0 |
| Tax Payable | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 |
| Other Curr. Liab. | $208 | $49 | $0 |
| Total Curr. Liab. | $608 | $715 | $41 |
| LT Debt | $310 | $325 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 |
| Total NC Liab. | $310 | $325 | $0 |
| Other Liabilities | $0 | $0 | $0 |
| Cap. Leases | $389 | $456 | $0 |
| Total Liabilities | $918 | $1,040 | $41 |
| Equity | – | – | – |
| Pref Stock | $0 | $0 | $0 |
| Common Stock | $49,153 | $36,997 | $1,922 |
| Retained Earnings | -$52,865 | -$30,421 | -$41 |
| AOCI | $6,278 | $6,117 | $20 |
| Other Equity | $575 | $508 | $0 |
| Total Equity | $3,141 | $13,200 | $1,901 |
| Supplemental Information | – | – | – |
| Minority Interest | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $4,059 | $14,240 | $1,943 |
| Net Debt | -$666 | -$8,945 | -$1,617 |